J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shelton, M. J.
Right arrow Articles by Morse, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shelton, M. J.
Right arrow Articles by Morse, G. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PHARMACOKINETICS AND PHARMACODYNAMICS

Delavirdine Malabsorption in HIV-Infected Subjects with Spontaneous Gastric Hypoacidity

Mark J. Shelton, PharmD, Ross G. Hewitt, MD, John M. Adams, PharmD, Steve R. Cox, PhD, James H. Chambers, BA and Gene D. Morse, PharmD

From GlaxoSmithKline, Research Triangle Park, North Carolina (Dr. Shelton); the Antiviral Clinical Pharmacology Unit (Dr. Hewitt, Dr. Morse), Immunodeficiency Services Clinic, Erie County Medical Center and the Laboratory for Antiviral Research (Dr. Hewitt, Dr. Morse), Departments of Pharmacy Practice and Medicine, University at Buffalo, Buffalo, New York and PharmaResearch Corporation, Morrisville, North Carolina (Dr. Adams); and Pharmacia and Upjohn, Inc., Kalamazoo, Michigan (Dr. Cox, Mr. Chambers)

To determine the impact of gastric hypoacidity and acidic beverages on delavirdine mesylate pharmacokinetics in HIV-infected subjects, matched subjects with (n = 11) and without (n = 10) gastric hypoacidity received delavirdine 400 mg tid with either water or an acidic beverage (usually orange juice). The pharmacokinetics of delavirdine and its N-desalkyl metabolite were determined over 8 hours after 14 days of each treatment. Gastric pH was measured at baseline and during each pharmacokinetic evaluation. Delavirdine exposure (Cmax, AUC0->8h, and Cmin) was 50% lower and the extent of delavirdine metabolism was higher in subjects with gastric hypoacidity. Orange juice produced a lower mean gastric pH compared to water and increased delavirdine absorption by 50% to 70% in subjects with gastric hypoacidity. However, orange juice had a marginal impact on delavirdine exposure in subjects without gastric hypoacidity. HIV-infected subjects with gastric hypoacidity significantly malabsorb delavirdine. Delavirdine administration with acidic beverages improves, but does not normalize, absorption in these subjects.

Address for reprints: Mark J. Shelton, PharmD, GlaxoSmithKline, Five Moore Drive, P.O. Box 1398, Research Triangle Park, NC 27709.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Clinical Pharmacology